Ameren Q2 EPS rises to $1.13 from $1.01; 2026 earnings guidance reaffirmed
Ameren reported second quarter 2026 net income attributable to common shareholders of $314 million, or $1.13 per diluted share, up from $275 million, or $1.01 per diluted share, a year earlier. Total operating revenues fell to $2.09 billion from $2.22 billion, and the company reaffirmed its 2026 earnings guidance range of $5.25 to $5.45 per diluted share.
Key points
- Q2 2026 diluted EPS of $1.13 vs. $1.01 in Q2 2025; net income attributable to common shareholders of $314 million vs. $275 million
- Total operating revenues of $2.09 billion vs. $2.22 billion in Q2 2025; six-month revenues of $4.27 billion vs. $4.32 billion
- Six-month diluted EPS of $2.41 vs. $2.08 in the prior-year period; 2026 earnings guidance of $5.25 to $5.45 per diluted share reaffirmed
- Analyst conference call scheduled for 9 a.m. Central Time on Friday, July 31, 2026
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.